The nanoparticle formula optimization from Temulawak extract (Curcuma xanthorrhiza) as adjuvant therapy
Downloads
Temulawak extract was synthesized using temulawak sodium alginate. The nanoparticle formula was obtained by combining the characteristics of temuwak extract and temusawak. The microbeads were characterized by scanning electron microscopy (SEM) and Fourier transform infrared (FTIR) spectroscopy. The size of Alg-Curcuma was measured at SEM. The particle size distribution of the sample was analyzed using FTIR spectra. The results showed that the size of the resulting beads is microparticle in size. It was found that the temurawak extract is a good candidate as an anticancer agent. Therefore, there are several recommendations that can be done to optimize the synthesis of the material. The study reported that the recommended parameter is 12.5 kV with a flow rate of 0.1 mL/h (first batch synthesis).
Aghebati?Maleki, A., Dolati, S., Ahmadi, M., Baghbanzhadeh, A., Asadi, M., Fotouhi, A., Yousefi, M., & Aghebati?Maleki, L. (2020). Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. Journal of Cellular Physiology, 235(3), 1962–1972.
Ali, E. S., Sharker, S. M., Islam, M. T., Khan, I. N., Shaw, S., Rahman, M. A., Uddin, S. J., Shill, M. C., Rehman, S., Das, N., Ahmad, S., Shilpi, J. A., Tripathi, S., Mishra, S. K., & Mubarak, M. S. (2021). Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Seminars in Cancer Biology, 69. https://doi.org/10.1016/j.semcancer.2020.01.011
Chivere, V. T., Kondiah, P. P. D., Choonara, Y. E., & Pillay, V. (2020). Nanotechnology-based biopolymeric oral delivery platforms for advanced cancer treatment. Cancers, 12(2). https://doi.org/10.3390/cancers12020522
Croissant, J. G., Butler, K. S., Zink, J. I., & Brinker, C. J. (2020). Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications. Nature Reviews Materials, 5(12). https://doi.org/10.1038/s41578-020-0230-0
de la Torre, P., Pérez-Lorenzo, M. J., Alcázar-Garrido, Á., & Flores, A. I. (2020). Cell-based nanoparticles delivery systems for targeted cancer therapy: Lessons from anti-angiogenesis treatments. In Molecules (Vol. 25, Issue 3). https://doi.org/10.3390/molecules25030715
Dong, X., Wu, Z., Li, X., Xiao, L., Yang, M., Li, Y., Duan, J., & Sun, Z. (2020). The Size-dependent Cytotoxicity of Amorphous Silica Nanoparticles: A Systematic Review of in vitro Studies. International Journal of Nanomedicine, 15. https://doi.org/10.2147/IJN.S276105
Gavas, S., Quazi, S., & Karpi?ski, T. M. (2021). Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Research Letters, 16(1). https://doi.org/10.1186/s11671-021-03628-6
Gomes, H. I. O., Martins, C. S. M., & Prior, J. A. V. (2021). Silver nanoparticles as carriers of anticancer drugs for efficient target treatment of cancer cells. Nanomaterials, 11(4). https://doi.org/10.3390/nano11040964
Hafeez, M. N., Celia, C., & Petrikaite, V. (2021). Challenges towards targeted drug delivery in cancer nanomedicines. Processes, 9(9). https://doi.org/10.3390/pr9091527
Ijaz, I., Gilani, E., Nazir, A., & Bukhari, A. (2020). Detail review on chemical, physical and green synthesis, classification, characterizations and applications of nanoparticles. Green Chemistry Letters and Reviews, 13(3). https://doi.org/10.1080/17518253.2020.1802517
Kashkooli, F. M., Soltani, M., & Souri, M. (2020). Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. Journal of Controlled Release, 327. https://doi.org/10.1016/j.jconrel.2020.08.012
Liu, Y., Miyoshi, H., & Nakamura, M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. International Journal of Cancer, 120(12), 2527–2537.
Oroojalian, F., Beygi, M., Baradaran, B., Mokhtarzadeh, A., & Shahbazi, M. A. (2021). Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy. Small, 17(12). https://doi.org/10.1002/smll.202006484
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021). Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. Seminars in Cancer Biology, 69. https://doi.org/10.1016/j.semcancer.2019.11.002
Rastogi, D., & Asa-Awuku, A. (2022). Size, Shape, and Phase of Nanoscale Uric Acid Particles. ACS Omega, 7(28). https://doi.org/10.1021/acsomega.2c01213
Shrestha, S., Wang, B., & Dutta, P. (2020). Nanoparticle processing: Understanding and controlling aggregation. Advances in Colloid and Interface Science, 279. https://doi.org/10.1016/j.cis.2020.102162
Tang, L., Mei, Y., Shen, Y., He, S., Xiao, Q., Yin, Y., Xu, Y., Shao, J., Wang, W., & Cai, Z. (2021). Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy. International Journal of Nanomedicine, 16. https://doi.org/10.2147/IJN.S321416
Thakkar, S., Sharma, D., Kalia, K., & Tekade, R. K. (2020). Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review. Acta Biomaterialia, 101. https://doi.org/10.1016/j.actbio.2019.09.009
Wang, Y., Pi, C., Feng, X., Hou, Y., Zhao, L., & Wei, Y. (2020). The influence of nanoparticle properties on oral bioavailability of drugs. International Journal of Nanomedicine, 15. https://doi.org/10.2147/IJN.S257269
Zein, R., Sharrouf, W., & Selting, K. (2020). Physical Properties of Nanoparticles That Result in Improved Cancer Targeting. Journal of Oncology, 2020. https://doi.org/10.1155/2020/5194780
Copyright (c) 2024 Greesty Finotory Swandiny, Safira Nafisa, Rahmatul Qodriah, Gumilar Adhi Nugroho, Muhammad Taher Bakhtiar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
